Skip to content

Arvinas ARVN Return on assets

Return on assets at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-47.2%+2.5pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-24.3%-2.2pp
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
-23%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-44.8%-17.9pp
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
-97.8%+25.9pp
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-51.4%+5.5pp

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Calculated from Arvinas’s reported figures.

Based on trailing twelve months.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's return on assets?
Arvinas (ARVN) reported return on assets of -26.8% in Q1 2026.
How has Arvinas's return on assets changed year-over-year?
Arvinas's return on assets decreased by 537.7% year-over-year, from -4.2% to -26.8%.
What is the long-term trend for Arvinas's return on assets?
Over 5 years (2020 to 2025), Arvinas's return on assets has grown at a -17.5% compound annual growth rate (CAGR), from -23.4% to -8.9%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.